6XH3
Co-crystal structure of HIV-1 TAR RNA in complex with lab-evolved RRM TBP6.3
6XH3 の概要
エントリーDOI | 10.2210/pdb6xh3/pdb |
分子名称 | TAR BINDING PROTEIN TBP 6.3, TRANS-ACTIVATION RESPONSE ELEMENT (3 entities in total) |
機能のキーワード | protein-rna complex, tar rna, lab-evolved protein, arginine fork, beta hairpin, major-groove readout, base triple, u1a, hiv-1, trans- activation, rna recognition motif, rrm, rna binding protein-rna complex, rna binding protein, rna binding protein/rna |
由来する生物種 | Homo sapiens (human) 詳細 |
タンパク質・核酸の鎖数 | 2 |
化学式量合計 | 18886.07 |
構造登録者 | |
主引用文献 | Chavali, S.S.,Mali, S.M.,Jenkins, J.L.,Fasan, R.,Wedekind, J.E. Co-crystal structures of HIV TAR RNA bound to lab-evolved proteins show key roles for arginine relevant to the design of cyclic peptide TAR inhibitors. J.Biol.Chem., 295:16470-16486, 2020 Cited by PubMed Abstract: RNA-protein interfaces control key replication events during the HIV-1 life cycle. The viral -activator of transcription (Tat) protein uses an archetypal arginine-rich motif (ARM) to recruit the host positive transcription elongation factor b (pTEFb) complex onto the viral -activation response (TAR) RNA, leading to activation of HIV transcription. Efforts to block this interaction have stimulated production of biologics designed to disrupt this essential RNA-protein interface. Here, we present four co-crystal structures of lab-evolved TAR-binding proteins (TBPs) in complex with HIV-1 TAR. Our results reveal that high-affinity binding requires a distinct sequence and spacing of arginines within a specific β2-β3 hairpin loop that arose during selection. Although loops with as many as five arginines were analyzed, only three arginines could bind simultaneously with major-groove guanines. Amino acids that promote backbone interactions within the β2-β3 loop were also observed to be important for high-affinity interactions. Based on structural and affinity analyses, we designed two cyclic peptide mimics of the TAR-binding β2-β3 loop sequences present in two high-affinity TBPs ( values of 4.2 ± 0.3 and 3.0 ± 0.3 nm). Our efforts yielded low-molecular weight compounds that bind TAR with low micromolar affinity ( values ranging from 3.6 to 22 μm). Significantly, one cyclic compound within this series blocked binding of the Tat-ARM peptide to TAR in solution assays, whereas its linear counterpart did not. Overall, this work provides insight into protein-mediated TAR recognition and lays the ground for the development of cyclic peptide inhibitors of a vital HIV-1 RNA-protein interaction. PubMed: 33051202DOI: 10.1074/jbc.RA120.015444 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (2.353 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード